| Structure |
Chemical Name |
CAS |
MF |
 |
CefathiaMidine Lactone |
905712-22-3 |
C17H24N4O4S2 |
 |
Cinacalcet IMpurity 9 |
802918-36-1 |
C22H24F3N |
 |
Doxorubicin IMpurity B |
106401-68-7 |
C29H34BrNO11 |
 |
EzetiMibe IMpurity B |
|
|
![Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one]](/CAS/20150408/GIF/CB42674319.gif) |
Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] |
1449785-88-9 |
C10H7F2N3O |
 |
HydroxyMethylidene thione |
1320360-86-8 |
C15H18N4OS |
|
|
Lansoprazole IMpurity I |
|
|
 |
Lapatinib IMpurity 10 |
1152131-73-1 |
C26H17ClFN3O4 |
|
|
Metronidazole IMpurity D |
|
|
 |
Methyl 2-CarbaMoylbenzoate |
90564-02-6 |
C9H9NO3 |
 |
3-vinylphenyl ethyl(Methyl)-carbaMate |
1346602-84-3 |
C12H15NO2 |
 |
AMisulpride IMpurity D |
71676-00-1 |
C16H25N3O4S |
|
|
AFuroseMide IMp. A (EP) |
|
|
 |
(1R)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid ethyl ester |
180468-41-1 |
C18H19NO2 |
![2-[4-[(RS)-(4-Chlorophenyl)phenylMethyl]-piperazin-1-yl]ethanolDihydrochloride](/CAS/20130318/GIF/CB42617044.gif) |
2-[4-[(RS)-(4-Chlorophenyl)phenylMethyl]-piperazin-1-yl]ethanolDihydrochloride |
|
C19H25Cl3N2O |
 |
CAPECITABINE related substance USP |
1262133-68-5 |
C20H30FN3O9 |
![4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide](/CAS/GIF/71676-01-2.gif) |
4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide |
71676-01-2 |
C17H27N3O5S |
![3-[(4-AMino-2-Methyl-5-pyriMidinyl)Methyl]-4-Methyl-5-[2-(sulfooxy)ethyl]thiazoliuM Inner Salt](/CAS/GIF/2380-61-2.gif) |
3-[(4-AMino-2-Methyl-5-pyriMidinyl)Methyl]-4-Methyl-5-[2-(sulfooxy)ethyl]thiazoliuM Inner Salt |
2380-61-2 |
C12H16N4O4S2 |
![1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine](/CAS/GIF/1365802-18-1.gif) |
1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine |
1365802-18-1 |
C52H48N12O2 |
![[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0](/CAS/20150408/GIF/79750-46-2.gif) |
[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0 |
79750-46-2 |
C16H17N3O4S |
 |
SalMeterol EP IMpurity D |
1391052-04-2 |
C34H47NO7 |
 |
3-Pyridinecarboxylic Acid 2-AMinoethyl Ester Dihydrochloride |
87330-70-9 |
C8H11ClN2O2 |
![3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione](/CAS/GIF/871700-24-2.gif) |
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
C18H15FIN3O4 |
 |
PeMetrexed EP IMpurity D |
144051-68-3 |
C25H28N6O9 |
 |
SuMatriptan EP IMpurity F |
2074615-63-5 |
C13H17N3O2S |
|
|
PraMipexole IMpurity V (PraMipexole IMpurity Z) |
|
|
 |
Prasugrel Acetyl IMpurity |
1443034-67-0 |
C18H18FNO3S |
|
|
Propofol IMpurity G |
|
|
 |
SalMeterol IMpurity A |
|
C25H37NO4 |
 |
Sitagliptin Defuoro IMpurity 3 |
851307-12-5 |
C15H19F2NO4 |
 |
Sitagliptin N-Boc IMpurity |
486460-23-5 |
C21H23F6N5O3 |
|
|
SulbactaM IMpurity D |
|
|
|
|
Valsartan N2-Trityl IMpurity |
|
|
 |
Vardenafil IMpurity 3 |
1255919-01-7 |
C26H30N6O4S |
 |
Montelukast Cyclopropaneacetonitrile |
866923-62-8 |
C35H35ClN2OS |
 |
(3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
461432-24-6 |
C22H27ClO7 |
 |
Ezetimibe Impurity |
1510820-22-0 |
C24H23F2NO2 |
|
|
10,13-bissidechainpaclitaxel |
|
|
|
|
Istradefylline Impurity A |
|
|
 |
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride |
|
C14H24Cl2N2 |
![2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole](/CAS/20150408/GIF/142384-07-4.gif) |
2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole |
142384-07-4 |
C14H12N4O3S |
 |
Valsartan Desvaleryl Impurity |
676129-92-3 |
C19H21N5O2 |
|
|
Istradefylline iMpurity |
|
|
 |
(E)-Olopatadine Hydrochloride |
949141-22-4 |
C21H24ClNO3 |
![(3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester](/CAS/GIF/204254-92-2.gif) |
(3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester |
204254-92-2 |
C15H26O7S |
![(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid](/CAS/GIF/205826-86-4.gif) |
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid |
205826-86-4 |
C13H17NO4 |
|
|
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid |
205826-86-4 |
C13H17NO4 |
 |
8-Hydroxy Pitavastatin |
224320-09-6 |
C25H24FNO5 |
 |
α-Decitabine |
22432-95-7 |
C8H12N4O4 |
 |
Aloin Peracetate |
64951-96-8 |
C37H38O17 |
![L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester](/CAS/20150408/GIF/1256490-52-4.gif) |
L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester |
1256490-52-4 |
C18H17F5NO5P |
 |
Cefditoren iMpurity 2, Cefditoren open ring |
1348409-50-6 |
C20H24N8O7S2 |
|
|
Ceftriaxone IMpurity C |
|
|
|
|
Etoricoxib iMpurity 2 |
|
|
|
|
Sugammadex sodium Org199129-1 Impurity |
|
|
|
|
Sugammadex sodium Impurity 41 |
|
|
 |
Apixaban Impurity 51 |
1620494-29-2 |
C33H32N4O5 |
 |
4-(5-methyl-2-phenyloxazol-4-yl)benzenesulfonamide |
2242749-01-3 |
C16H14N2O3S |
|
|
Cefazolin Impurity EP-I |
|
|
|
|
Cabozantinib impurity 42 |
|
|
|
|
Cabozantinib impurity 55 |
|
|
|
|
Canagliflozin Impurity 68 |
|
|
|
|
Bumetanide Impurity 23 |
|
|
|
|
Rocuronium Bromide Impurity 34、35、36 |
|
|
 |
Vinpocetine impurity C |
70155-05-4 |
C23H28N2O3 |
|
|
Cloxacillin Impurity X |
|
|
|
|
1-(4-((2-(4-hydroxypiperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxamide |
|
|
|
|
Azilsartan Impurity 107 |
|
|
|
|
Perospirone Impurity 25 |
|
|
|
|
Paxlovid Impurity 16 |
|
|
|
|
3-(2-(cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
|
|
Fondaparinux sodium impurity 17 |
|
|
|
|
Fondaparinux sodium impurity 12 |
|
|
|
|
Piperacillin impurity L |
|
|
|
|
Piperacillin Impurity X |
|
|
 |
ETHYLTRITYLETHER |
968-39-8 |
C21H20O |
|
|
Bosutinib Impurity 41 |
|
|
 |
(S)-3-Dimethylamino-3-phenylpropanol |
82769-75-3 |
C11H17NO |
|
|
Valdecoxib N-Oxide |
|
|
|
|
Olodaterol Impurity 23 |
|
|
|
|
Miglitol Isomer impurities C |
|
|
|
|
Alpha-D-Methylglucoside |
|
|
 |
4-Desacetyl Vincristine |
3704-01-6 |
C44H54N4O9 |
|
|
Relugolix Impurity 91 |
|
|
 |
D,L N-Desmethylvenlafaxine |
149289-30-5 |
C16H25NO2 |
 |
PIVALOYLOXYMETHYL 6-AMINOPENICILANATE |
25031-08-7 |
C14H22N2O5S |
![1H-Benzimidazole, 6-chloro-7-methyl-2-[(2S)-2-methyl-2-pyrrolidinyl]-](/CAS/20210305/GIF/1788946-71-3.gif) |
1H-Benzimidazole, 6-chloro-7-methyl-2-[(2S)-2-methyl-2-pyrrolidinyl]- |
1788946-71-3 |
C13H16ClN3 |
 |
(9S)-9-Amino-9-deoxoerythromycin |
26116-56-3 |
C37H70N2O12 |
 |
NSC525120 |
10221-08-6 |
C8H7Cl3 |
 |
3-(2-cyanoethyl-(2-hydroxyethyl)amino)propanenitrile |
6305-56-2 |
C8H13N3O |
![TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL](/CAS/20150408/GIF/46727-91-7.gif) |
TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL |
46727-91-7 |
C13H20N2O |
|
|
Citalopram Related Compound F |
|
|
 |
(+)-Tamsulosin |
106138-88-9 |
C20H28N2O5S |
 |
2-Pyrrolidinecarboxamide,1-(hydroxyacetyl)-,(S)-(9CI) |
96166-39-1 |
C7H12N2O3 |
 |
1H-Pyrazole,3-ethoxy-5-methyl-1-phenyl-(9CI) |
300543-31-1 |
C12H14N2O |
 |
(2-PHENOXY)METHYLSULFONYLANILINE |
51765-51-6 |
C13H13NO3S |
![O-phenyl N-[4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluorobenzoyl]-N-methylcarbamothioate](/CAS/20240320/GIF/2894796-78-0.gif) |
O-phenyl N-[4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluorobenzoyl]-N-methylcarbamothioate |
2894796-78-0 |
C28H19F4N5O3S2 |
 |
5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (Z,E,Z)- (8CI) |
3879-25-2 |
C23H38O |
 |
4-methoxy-2,3,5-trimethylpyridine |
109371-19-9 |
C9H13NO |
 |
Lorcaserin iMpurity D |
1030624-36-2 |
C11H14ClNO2 |